What is the Impact Factor of Critical Reviews in Oncology Hematology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Critical Reviews in Oncology Hematology is 6.20, ranking in quartile Q1 of Web of Science (SCIE).

Is Critical Reviews in Oncology Hematology indexed in Web of Science or Scopus?

Yes, Critical Reviews in Oncology Hematology is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.977 (Q1) and an H-index of 160.

Who publishes Critical Reviews in Oncology Hematology and what is the Article Processing Charge (APC)?

Critical Reviews in Oncology Hematology is published by Elsevier Ireland Ltd. The estimated Article Processing Charge (APC) is approximately $3,660 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Critical Reviews in Oncology Hematology?

The official ISO-4 abbreviation of Critical Reviews in Oncology Hematology is "CRIT REV ONCOL HEMAT" with common acronym "croh". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #1,483Top JournalReview JournalHybrid

Critical Reviews in Oncology Hematology

Acronym:croh

•

Abbreviation (ISO):CRIT REV ONCOL HEMAT

•

Identifier (ISSN):1040-8428(Print)/1879-0461(Online)

•

Publisher:Elsevier Ireland Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

6.2↑ +0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Critical Reviews in Oncology Hematology

WoS Q1

Annual Impact Factor Metric

Current (2026):6.2

Scopus SJR & RankScopus Q1

1.977

#1,483

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

160

160 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate1.8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

250articles/year

31.46% Gold OA•0% Original Research

Aims & Scope

Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.

Topics Covered (Recognized by AI)

Medicine99.7%Biology83.1%Internal medicine82.4%Genetics76.8%Cancer58.4%Pathology54%Oncology46%Surgery43.7%Chemistry37.9%Biochemistry32.7%Immunology30%Chemotherapy23.5%Cancer research23%

Primary Research Areas

Medicine Hematology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

HEMATOLOGY

Rank15/103

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank60/333

IndexSCIE

JCISCIE2026

HEMATOLOGY

Rank25/103

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank117/333

IndexSCIE

Category	Index	Rank	Quartile
HEMATOLOGY	JCRSCIE	15/103	Q1
ONCOLOGY	JCRSCIE	60/333	Q1
HEMATOLOGY	JCISCIE	25/103	Q1
ONCOLOGY	JCISCIE	117/333	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF6.2

Articles / Year410

Total Citations363

2025

IF5.6

Articles / Year417

Total Citations2,594

2024

IF5.5

Articles / Year280

Total Citations3,484

2023

IF6.2

Articles / Year212

Total Citations3,485

2022

IF6.625

Articles / Year211

Total Citations5,880

Year	Impact Factor	Articles / Year	Total Citations
2026	6.2	410	363
2025	5.6	417	2,594
2024	5.5	280	3,484
2023	6.2	212	3,485
2022	6.625	211	5,880
2021	6.312	246	6,640
2020	5.833	240	9,426
2019	5.012	202	8,988
2018	4.495	191	8,297
2017	—	202	12,957
2016	—	197	9,554
2015	—	199	10,829

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,483Scopus Q1SCImago Profile

Scopus Coverage:1983-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.977

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

6.71

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,660 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations4,409

3-Year Documents644

Citable Documents639

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Geriatrics and GerontologyQ1

HematologyQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 1.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Critical Reviews in Oncology Hematology (acronym: croh, abbr: CRIT REV ONCOL HEMAT, ISSN: 1040-8428) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ireland Ltd in United States since 1983. The periodical holds a Journal Impact Factor (JIF) of 6.20, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.977 (Q1), an H-index of 160.

The journal enforces rigorous peer evaluation with an average review speed of 27.3周, a publication frequency of Monthly, an annual output of approximately 250 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,660 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.